Follow
Salvatore De Rosa
Salvatore De Rosa
Magna Graecia University
Verified email at unicz.it
Title
Cited by
Cited by
Year
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
76992017
Circulating microRNAs in patients with coronary artery disease
S Fichtlscherer, S De Rosa, H Fox, T Schwietz, A Fischer, C Liebetrau, ...
Circulation research 107 (5), 677-684, 2010
14832010
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ...
European heart journal 41 (22), 2083-2088, 2020
10172020
Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links
S De Rosa, B Arcidiacono, E Chiefari, A Brunetti, C Indolfi, DP Foti
Frontiers in endocrinology 9, 334630, 2018
3522018
Transcoronary concentration gradients of circulating microRNAs
S De Rosa, S Fichtlscherer, R Lehmann, B Assmus, S Dimmeler, ...
Circulation 124 (18), 1936-1944, 2011
3232011
Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries
G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ...
Atherosclerosis 285, 135-146, 2019
3032019
Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature
D Erkapic, S De Rosa, A Kelava, R Lehmann, S Fichtlscherer, ...
Journal of cardiovascular electrophysiology 23 (4), 391-397, 2012
2842012
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
P Cirillo, P Golino, P Calabro, G Calì, M Ragni, S De Rosa, G Cimmino, ...
Cardiovascular research 68 (1), 47-55, 2005
2182005
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ...
European heart journal 43 (7), e17-e25, 2022
1852022
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR
NM Van Mieghem, M Unverdorben, C Hengstenberg, H Moellmann, ...
New England Journal of Medicine 385 (23), 2150-2160, 2021
1732021
Patient selection and timing of continuous renal replacement therapy
M Ostermann, M Joannidis, A Pani, M Floris, S De Rosa, JA Kellum, ...
Blood purification 42 (3), 224-237, 2016
1692016
MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis
C Eyileten, Z Wicik, S De Rosa, D Mirowska-Guzel, A Soplinska, C Indolfi, ...
Cells 7 (12), 249, 2018
1532018
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review
J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik, C Eyileten, S De Rosa, ...
Cardiovascular diabetology 18, 1-19, 2019
1302019
Emerging role of microRNAs in cardiovascular diseases
S De Rosa, A Curcio, C Indolfi
Circulation Journal 78 (3), 567-575, 2014
1272014
MicroRNAs for restenosis and thrombosis after vascular injury
C Gareri, S De Rosa, C Indolfi
Circulation research 118 (7), 1170-1184, 2016
1262016
Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis
J Sabatino, S De Rosa, G Di Salvo, C Indolfi
PloS one 15 (8), e0237131, 2020
1192020
The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no …
K Hemmann, M Sirotina, S De Rosa, JR Ehrlich, H Fox, J Weber, A Moritz, ...
Interactive cardiovascular and thoracic surgery 17 (2), 359-364, 2013
1162013
Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: primary results of the international multicenter iFR …
Y Kikuta, CM Cook, ASP Sharp, P Salinas, Y Kawase, Y Shiono, ...
JACC: Cardiovascular interventions 11 (8), 757-767, 2018
1132018
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study
L De Luca, S Leonardi, C Cavallini, D Lucci, G Musumeci, R Caporale, ...
European Heart Journal: Acute Cardiovascular Care 4 (5), 441-452, 2015
1132015
Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach?
SD Rosa, P Cirillo, A Paglia, L Sasso, VD Palma, M Chiariello
Current vascular pharmacology 8 (2), 259-275, 2010
1102010
The system can't perform the operation now. Try again later.
Articles 1–20